Inspiring news from Manchester: Cancer can be cured in 11 days

Breast cancer is the most common cancer among women. According to statistics, every eighth representative of the fair sex suffers from this terrible disease. But for now. breast cancer It can be successfully treated. Recent research in the UK is encouraging!





"Site" Innovative clinical experience of scientists from the Institute of cancer research in London, which gives millions of women hope for recovery.

Breast Cancer Treatment New study reveals amazing impact on HER2-positive breast cancer in just 11 days! As it turned out, the combination of lapatinib and trastuzumab (herceptin) can be successfully used for the treatment of breast cancer. These drugs are widely used in the treatment of breast cancer, but this is the first time they have been used simultaneously.

On the basis of the Institute of Cancer Research in London, the University of Manchester and the University Hospital of South Manchester, a study was conducted on a new method of treating breast cancer. 257 women with HER2-positive breast cancer were divided into groups and treated for 11 days before surgery.





Part of the subjects underwent therapy with a combination of drugs, and part - only one of the drugs. To best assess the results of the study, samples of infected tissue were taken from the original biopsy and during surgery.

The results showed that women who took the combination of drugs did not have a noticeable decrease in the protein Ki67, responsible for tissue repair. However, 11% of these women were classified as having a pathologically complete response. That is, active cancer cells in their body. found not. 17% of subjects who took both drugs had minimal residual disease.





Trastuzumab and lapatinib - drugs aimed at cancerouswhich expresses the HER2 protein. Traditional chemotherapy is aimed at destroying absolutely all fast-growing cells, including healthy cells of the body, and this entails a lot of negative side effects.

The greatest advantage of this approach to the treatment of breast cancer is that in the future it is able to get rid of further chemotherapy and surgery. This means that patients will not have to suffer from treatment side effects such as hair loss, vomiting and unbearable fatigue.





“Our findings provide a solid basis for further research into combination anti-HER2 therapy prior to surgery.” This can reduce the number of women who require subsequent chemotherapy, which is also very effective, but can lead to long-term side effects, says lead researcher at the Cancer Institute Judith Bliss.

According to statistics, one in five women with breast cancer has the most aggressive form. HER2-positive breast cancer. Although these studies are not a panacea, nevertheless, this medical breakthrough will serve as a solid basis for further research and treatment of the terrible disease.





There is hope for recovery! God forbid that scientists succeed, because such treatment can save patients from chemotherapy after surgery, reduce the risk of adverse side effects and give patients hope for a better quality of life.

We must not forget that prevention is the best medicine. Timely examinations by a mammologist and gynecologist, breast self-examination and a healthy lifestyle are the key to women’s health!

Don’t forget to share this inspirational article with your friends on social media. Bless you!